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An agonist-occupied β2-adrenergic receptor (β2-AR) recruits G protein receptor kinase-2 (GRK2) which is recruited to the
membrane. Thus, the physical proximity of activated β2-AR and PI-3K allows the activation of the latter. In contrast, it has been
observedthattheβ1-ARisunabletoactivatethePI-3K/Aktpathway.Wehypothesizedthatthediﬀerencemightbeduetomolecular
determinants present in the carboxy termini of the two β-AR subtypes. Using transiently transfected HEK 293 cells expressing
either β1-o rβ2-AR, we also observed that in presence of an agonist, β2-AR, but not β1-AR, is able to activate the PI-3K/Akt
pathway. Switching the seventh transmembrane domain and the carboxy tail between the two receptors reverses this phenotype;
that is, β1 × β2-AR can activate the PI-3K/Akt pathway whereas β2 × β1-AR cannot. Pretreatment with pertussis toxin abolished
the activation of PI-3K by β2-o rβ1 × β2-AR stimulation. Ligand-mediated internalization of the β2-AR induced by a 15-minute
stimulation with agonist was abolished in the presence of a dominant negative of PI-3K or following pertussis toxin pretreatment.
Theseresultsindicatethatthesubtype-speciﬁcdiﬀerencesinthecouplingtoPI-3K/Aktpathwayareduetomoleculardeterminants
present in the carboxy tail of the receptor and further that β2-AR activates PI-3K via a pertussis toxin-sensitive mechanism.
Copyright © 2009 Julie Simard et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
β2-AR activation induces antiapoptotic eﬀects in cardiomy-
ocytes mediated by stimulation of the PI-3K pathway [1].
The proposed mechanism by which this activation occurs is
dependent on G protein-coupled receptor kinases (GRKs).
Under basal conditions, GRK2 forms a complex with PI-3K
in the cytosol [2]. When β2-AR is occupied by an agonist,
GRK2 is translocated to the membrane by a Gβγ subunit-
dependentmechanismandsubsequentlyrecruitsPI-3Kfrom
the cytosol to the membrane [2]. The proximity of the PI-
3K and the stimulated receptor induces the activation of
the enzyme. In contrast, β1-AR has proapoptotic activity in
cardiomyocytes due to stimulation of PKA or CAM KII [3].
Indeed, it has been observed that stimulation of β1-AR with
an agonist induces apoptosis and this can be prevented in
presence of inhibitors of either PKA or CAM-KII [4].
Interestingly it has been shown that stimulated β1-AR
can also recruit GRK to the membrane. The interaction
of either β-AR subtype with GRKs is mainly via the
intracellular loops and carboxy tail of the receptor [5].
Whenactivated,GRKinducesthephosphorylationofcertain
serine/threonine residues in the carboxy tail of both β-AR
subtypes resulting in functional uncoupling of the receptor
from their primary signalling pathways. GRK2 phosphory-
lation also favours subsequent interaction with β-arrestin.
This interaction with β-arrestin further desensitizes the
receptorandissubsequentlyinvolvedinreceptorendocytosis
[6, 7].
As GRK interacts with molecular determinants in car-
boxy tail of the receptor, we hypothesized that diﬀerences in
the coupling of the β1-a n dβ2-AR with PI-3K may be due
to determinants located in this portion of the receptor. This
study was designed to determine the respective eﬃciencies of2 International Journal of Cell Biology
β1-AR and β2-AR to stimulate the PI-3K pathway and to test
the above hypothesis.
2.MaterialandMethods
2.1. DNA Constructions, Cell Transfection, and Culture.
Murine β1-AR and human β2-AR subcloned into pcDNA3
were used in this study. Two chimeric receptors consisting of
the β1-AR with the seventh transmembrane domain and the
carboxyl-terminal tail of the β2-AR and the reciprocal β2-AR
with the seventh transmembrane domain and the carboxyl-
terminal tail of the β1-AR were constructed as follows. A
restriction site for Hpa I was created by polymerase chain
reaction (PCR) at position 2070 in the β1-AR. The new
restriction site in the β1-AR was created with three primers.
Two primers were used for the hybridation with the receptor
sequence. These primers contained 21 base pairs and had,
respectively, CGCCTCAGAAGCCATAGAGCC and TCG-
TGTGCACAGTGTGGGCCA sequences. The third primer
was utilized to introduce the restriction site. This primer
which contained 24 base pairs had the following sequence:
GGTGGAAAGCGTTAACCACGTTGG. The mutated β1-AR
and the β2-AR wt were double digested with Hpa I and Xho
I. The result of this digestion is two fragments of 6540bp and
486bp for the mutated β1-AR and two fragments 5998bp
and 1362bp for the β2-AR wt. The appropriate restriction
fragments (containing the seventh transmembrane domain
and the carboxy-terminal portion of the receptor) were
isolated, exchanged for their counterparts, and religated.
Positive clones were selected by enzymatic digestion and
conﬁrmed by sequencing.
The β-AR wild type (wt), chimeric receptors, dominant-
negative PI-3 kinase (p85ΔPI-3K), and/or carboxy-terminal
domain of GRK2 (ct-GRK2) were transiently transfected
in human embryonic kidney (HEK 293) cells using the
calcium phosphate precipitation method. We performed all
experiments at 48 hours posttransfection, that is, at maximal
receptor expression determined by ligand binding. Cells
were starved overnight 24 hours before the experiments
in a medium without fetal bovine serum. HEK 293 cells
were maintained in DMEM supplemented with 10% fetal
bovine serum, 100U/mL penicillin and streptomycin, 1mM
glutamine, 0.25μg/mL fungizone in an atmosphere of 95%
air/5% CO2 at 37◦C. On the day of the experiment, cells were
treated with 1μM isoproterenol for the indicated times and
fractionated for the cytosolic or membrane compartments.
In some experiments, cells were pretreated with pertussis
toxin (0.1μg/mL; Sigma), 18 hours before stimulation with
isoproterenol.
2.2. Preparation of Cytosolic and Membrane Fractions. Cells
were washed three times with 10mL of phosphate-buﬀered
saline at 4◦C and mechanically detached in 1mL of ice-
cold buﬀer containing 5mM Tris-HCl, pH 7.4, 2mM EDTA,
5μg/mL leupeptin, 5μg/mL soybean trypsin inhibitor, and
10μg/mL benzamidine. Cells were then lysed with a sonica-
tor (3 bursts of 10 seconds at max speed), and the lysates
were centrifuged at 1000 × gf o r5m i n u t e sa t4 ◦C. The
supernatant was centrifuged at 45000 × gf o r2 0m i n u t e s
and was considered as the cytosolic preparation. Protein
content was assessed using the Bradford method (Bio-Rad).
The pelleted membranes were resuspended in 250μLo fa
solubilization buﬀer (buﬀer A) containing 50mM Tris pH
7.5, 20mM β-glycerophosphate, 20mM NaF, 5mM EDTA,
10mM EGTA, 1mM Na3VO4, 10mM benzamidine, 0.5mM
PMSF, 10μg/mL leupeptin, 5mM DTT, 1μM microcystin
LR, and 1% Triton X-100; and solubilized for 2 hours at 4◦C.
Then the membranes were centrifuged at 10000 × gf o r1 5
minutes. The protein content was assessed using the Lowry
method (Bio-Rad).
2.3. Radioligand Binding Assay. Radioligand binding assays
were conducted essentially as described previously [8]w i t h
∼5μg of membrane proteins in a total volume of 0.5mL
containing 250 pM [125I]CYP in the presence or absence
of 10μM alprenolol to deﬁne nonspeciﬁc binding. The
binding reactions were incubated at room temperature for
90 minutes and terminated by rapid ﬁltration with ice-cold
25mM Tris-HCl, pH 7.4, over Whatman GF/C glass ﬁber
ﬁlters preincubed for ≥30 minutes in a buﬀer containing
25mM Tris-HCl, pH 7.4, 0.1% bovine serum albumin, and
0.3% polyethylenimine.
2.4. Western Blotting. Western blotting was conducted as
described previously [9]. Brieﬂy, aliquots of 50–75μgo f
cytosolic or membrane protein preparations were subjected
to 10% denaturing polyacrylamide gel electrophoresis as
previously described. Transfer was performed with a Trans-
BlotSDSemi-drytransfercell(Bio-Rad)onProtrannitrocel-
lulose membrane (Mandel, Montr´ eal, QC, Canada). Protein
transfer eﬃciency was assessed using Ponceau S staining.
Membranes were blocked using 5% nonfat dry milk in TBS-
T (10mM Tris (pH 7.4), 150mM NaCl, and 0.05% Tween
20) and membranes were incubated at 4◦C overnight with
primary antibody (anti-Phospho-Akt (Ser 473) and anti-
AktfromCellSignalingTechnology,(Missisauga,Canada)or
anti-PI-3K, anti-β1- or anti-β2-AR from Santa-Cruz (Calif,
USA) diluted 1:1000 in 5% nonfat dry milk into TBS-
T. Subsequently, membranes were washed and incubated
for 45 minutes at room temperature with the secondary
antibody (diluted 1:5000 in 5% nonfat dry milk into TBS-
T) conjugated to horseradish peroxidase. Membranes were
washed and exposed to scientiﬁc imaging ﬁlm (Perkin Elmer
Life Sciences, ON) or quantiﬁed using a Kodak ImageStation
440CF using enhanced chemiluminescence reagent (Perkin
Elmer Life Sciences). Band intensities were analyzed using
Kodak 1D v.3.5.5 Scientiﬁc Imaging Software.
2.5. Immunohistochemistry and Receptor Internalization.
Sequestration of β-AR was observed by immunolocalisation.
After agonist treatment, cells were washed with PBS and
ﬁxed with 3% paraformaldehyde for 15 minutes. After
these washes, nonspeciﬁc sites were blocked with 0.2%
BSA and 0.15% Triton x-100 (blocking solution) for 10
minutes. Primary antibody (β1-a n dβ2-AR from Santa-
Cruz), prepared in the blocking solution (1:200), was added
for 30 minutes at room temperature. After another seriesInternational Journal of Cell Biology 3
of washes, secondary antibody (antirabbit, Santa-Cruz,) also
prepared in the blocking solution (1:500) was added for 30
minutes. After a ﬁnal series of washes, slides were mounted
and viewed using a Leica epi-illumination microscope.
2.6. PI-3K Activity. PI-3K activity was measured as pre-
viously described [10]. Brieﬂy, 250–375μg of cytoso-
lic and membrane proteins were precipitated with anti-
phosphotyrosine antibody conjuged to biotin (1:50, Santa-
Cruz, Calif, USA) overnight at 4◦C. The immune complex
was pelleted (with streptavidin beads) and washed three
times with lysis buﬀer and twice with phosphate-buﬀered
saline buﬀer containing 0.1mM Na3VO4. The immune
pellet was then suspended in activation buﬀer (35mM
ATP, 0.2mM adenosine, 30mM MgCl2,1 0 m g / m LL - α-
phosphatidylinositol, and 20μCi [γ32P]-ATP; (Amersham
Pharmacia Biotech, Baie-d’Urf´ e, Canada) and incubated
at room temperature for 20 minutes. The reaction was
stopped with the addition of 100μL HCl 1M and 200μL
of chloroform:methanol (1:1). The aqueous phase was then
discarded. Eighty μL of HCl:methanol (1:1) were then
added before discarding the aqueous phase. Twenty μLo f
the organic phase containing 32P-phosphatidylinositol were
resolvedbythinlayerchromatographyonK6SilicaGelplates
(Whatman, Clifton, NJ, USA) in a solvent system contain-
ing chloroform:methanol:ammonium hydroxide (45:35:10).
Plates were exposed to ﬁlm for three to ﬁve days (−80◦C).
2.7. Statistical Analysis. Results are expressed as mean ±
SEM and were evaluated using analysis of variance adapted
for factorial experimental design. Orthogonalization was
performed when necessary [11]. P<. 05 was considered
signiﬁcant.
3. Results
3.1. Expression of β-AR Subtypes and p85ΔPI-3K in HEK
293 Cells. HEK 293 cells were transiently transfected with
cDNAs encoding for β1-AR Wt, β2-AR Wt, β1 × β2-AR, or
β2 × β1-AR and in some case, p85ΔPI-3K. Forty-eight hours
after transfection β-AR expression levels were approximately
500fmol/mg of proteins (compared to 10–20fmol/mg in
untransfectedcells).Expressionofp85ΔPI-3Kdeterminedby
western blot was increased 3.24 times as compared to wild-
type cells (data not shown, n = 3).
3.2. Stimulation of β2-AR but not β1-AR Induces Activation
of PI-3K/Akt Pathway. PI-3K activation by the β1-o rβ2-
AR was measured by in vitro phosphorylation of L-α-
phosphatidylinositol. Transfected cells were stimulated with
isoproterenol 1μM for 0, 5, or 15 minutes at 37◦C. Stimu-
lation of β2-AR- for 5 or 15 minutes induced a signiﬁcant
augmentationinPI-3Kactivitycomparedtobasalconditions
(nonstimulated; Figure 1). In contrast, β1-AR stimulation
had no eﬀect on PI-3K activity. Thus, the stimulation of
β2-AR but not β1-AR by isoproterenol induces activation
of PI-3K in our model. We suspect that the apparent
high basal level of PI-3K activation observed in our cell
0
100
200
300
B
a
s
a
l
(
%
)
0 5 15 0 5 15
Minutes
[32P]-PIP
∗ ∗
Figure 1: PI-3K activity with β-AR stimulation. HEK 293 cells
were transfected with β1-AR or β2-AR. Forty-eight hours after
transfection, cells were stimulated with 1μM isoproterenol for
the indicated times. PI-3K activity was determined by the level
of [32P]-PI produced by the stimulation of β1-AR ()o rβ2-AR
() expressing cells. Top panel is a representative autoradiograph
of TLC separation (n = 4-5). Data from these experiments is
quantitated in the bottom panel as described in Section 2. ∗P<. 05
versus 0 minute.
line may be due to the phosphotyrosine antibody used to
immunoprecipitate the activated PI-3K. Using this antibody,
we immunoprecipitate other PI-3K subtypes as well as
phosphotyrosine proteins that although not activated by β-
AR may still contribute to the basal level of activation.
To conﬁrm diﬀerences between stimulation of the two β-
AR subtypes on PI-3K activity, we used a measure of Akt
(a downstream PI-3K eﬀector) activation. Akt activation,
as determined by the phosphorylation status of Serine 473,
was signiﬁcantly increased after β2-AR-stimulation for 5
and 15 minutes as compared to the basal state (Figure 2).
Stimulation of β1-AR did not modify the phosphorylation
status of Akt as compared to control, conﬁrming that
β1-AR activation cannot stimulate PI3-kinase/Akt pathway
activation. Stimulation of untransfected HEK293 with iso-
proterenol did not result in any signiﬁcant activation of Akt
(data not shown).
3.3. Stimulation of Either β1-o rβ2-AR Induces PI-3K Recruit-
ment to the Plasma Membrane. To determine whether β1-
AR can recruit PI-3K to the plasma membrane, immunolo-
calisation of PI-3K was performed using Western blotting
with anti-P110γ antibody. Transiently transfected cells with
β1-o rβ2-AR were stimulated by isoproterenol 1μMf o r0 ,
5, or 15 minutes at 37◦C. Both β1-a n dβ2-AR stimulation
results in recruitment of PI-3K to the particulate fraction
(Figure 3). Compared with control (i.e., nonstimulated
cells), the presence of PI-3K was signiﬁcantly increased (P<
.05) in membrane fractions by agonist stimulation of either
β1-ARorβ2-ARfor5or15minutes.Nosigniﬁcantdiﬀerence
was detected between 5 and 15 minutes of stimulation. Thus,
either subtype of β-AR can recruit PI-3K to the membrane4 International Journal of Cell Biology
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Figure 2: Akt activation following β-AR stimulation. HEK 293 cells
were transfected with β1-AR or β2-AR. Forty-eight hours after
the transfection, cells were stimulated with 1μM isoproterenol
for the indicated times. Akt activation status was determined by
immunoblot for the phosphorylated form of Akt compared to the
total amount of Akt after stimulation of β1-AR ()o rβ2-AR ()
expressing cells. Top panel is a representative immunoblot of the
experiments (n = 4-5). Data from these experiments is quantitated
in the bottom panel as described in Section 2. ∗P<. 05 versus 0
minute.
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Figure 3: PI-3K Partitioning of PI-3K to the membrane.F o r t y -
eight hours after transfection, cells were stimulated with 1μM
isoproterenol for the indicated times. Membranes were isolated,
solubilized, and approximately 100μg of membrane proteins were
separated on a 10% SDS-PAGE gel. Membrane-associated PI-3K
levels increased with cells expressing β1-AR ()o rβ2-AR (). Top
panel is a representative immunoblot of the experiments (n = 3-4).
Data from these experiments is quantitated in the bottom panel as
described in Section 2. ∗P<. 05 versus 0 minute.
after agonist stimulation but only the β2-AR results in PI-3K
activation.
3.4. Recruitment of PI-3K to the Plasma Membrane is Gβγ
Subunit-Dependent. IthasbeenshownthatPI-3KandGRK2
form a cytosolic complex [2]. To determine whether the
mechanism of PI-3K recruitment to the plasma membrane
was Gβγ subunit-dependent, β1-o rβ2-AR was transiently
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Figure 4: GRK2 carboxy-terminal domain reduced PI-3K recruit-
ment to membrane fractions in response to β-AR stimulation.H E K
293 cells were cotransfected with ct-GRK-2 and β-AR subtypes.
Forty-eight hours after the transfection, cells were stimulated
with 1μM isoproterenol for 5 minutes. PI3-kinase recruitment to
particulate fractions decreased with cells expressing either β1-AR
()o rβ2-AR () in presence of cotransfected ct-GRK2. Top panel
is a representative immunoblot of the experiments (n = 4–6).
Data from these experiments is quantitated in the bottom panel as
described in Section 2. ∗P<. 05 versus 0 minute.
cotransfected with the carboxyl-terminal portion (ct) of
GRK2 (a sequestering agent for Gβγ) in HEK 293 cells.
Cells cotransfected with β1-o rβ2-AR and ct-GRK2 were
stimulated with 1μM isoproterenol for 5 minutes. ct-GRK2
when transfected alone had no eﬀect on PI-3K activity.
Stimulation of the β2-AR for 5 minutes with isoproterenol
in cells cotransfected with ct-GRK2 resulted in a signif-
icantly decreased (P<. 001) PI-3K recruitment to the
particulate fraction (Figure 4) as compared to stimulation
of the β2-AR expressed alone. Similar results were obtained
when cells expressing the β1-AR were stimulated for 5
minutes with the agonist, that is, the presence of ct-GRK2
signiﬁcantly decreased (P<. 001) PI-3K recruitment to
membranes (Figure 4). Thus, PI-3K recruitment to the
plasma membrane by either β1-o rβ2-AR stimulation is
Gβγ subunit-dependent although only β2-AR-dependent
recruitment results in subsequent PI-3K activation.
3.5. PI-3K/Akt Pathway Activation Following Stimulation
of Chimeric β1 × β2-AR and β2 × β1-AR . To determine
the importance of receptor-speciﬁc determinants in the β-
AR carboxy tail for PI-3K activation, we constructed two
chimeric receptors which consisted of the β1-AR with the
proximal seventh transmembrane domain and carboxy-
terminal tail of the β2-AR (β1 × β2-AR) as well as the
reciprocal receptor which consisted of β2-AR with the
carboxy-terminal tail of the β1-AR (β2 × β1-AR). When the
β1 × β2-AR was stimulated by 1μM isoproterenol for 5 or
15 minutes, PI3-kinase activity was signiﬁcantly increased
(Figure 5;P<. 05).Ontheotherhand,agoniststimulationof
the β2×β1-AR for 5 or 15 minutes did not result in increased
PI3-kinase activity. These results suggest that the carboxy-
terminal tail of the β2-AR contains molecular determinants
which are required for PI3-kinase activation.International Journal of Cell Biology 5
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Figure 5: PI-3K activity with chimeric β-AR stimulation.H E K
293 cells were transfected with β1 × β2-AR or β2 × β1-AR. Forty-
eight hours after transfection, cells were stimulated with 1μM
isoproterenolfortheindicatedtimes.PI-3Kactivitywasdetermined
by the level of [32P]-PI produced by the stimulation of β1 × β2-AR
()o rβ2×β1-AR () expressing cells. Top panel is a representative
autoradiograph of the TLC separation (n = 4-5). Data from these
experiments is quantitated in the bottom panel as described in
Section 2. ∗P<. 05 versus 0 minute.
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Figure 6:Aktactivitywithchimericβ-ARstimulation.HEK293cells
were transfected with β1 × β2-AR or β2 × β1-AR. Forty-eight hours
after the transfection, cells were stimulated with 1μM isoproterenol
for the indicated times. Akt activity was determined by measuring
levels of phosphorylated Akt compared with total Akt produced by
thestimulationofβ1×β2-AR()orβ2×β1-AR()expressingcells.
Upper panel is a representative immunoblot of the experiments
(n = 6-7).Datafromtheseexperimentsisquantitatedinthebottom
panel as described in Section 2. ∗P<. 05 versus 0 minute.
To conﬁrm results obtained for the PI-3K activation
mediated by the two chimeric β-ARs, we again determined
the activation status of Akt. Chimeric receptors were stim-
ulated with 1μM isoproterenol for 0, 5, or 15 minutes at
37◦C. Akt phosphorylation was signiﬁcantly increased (P<
.05) in HEK 293 cells expressing β1 × β2-AR (Figure 6).
Stimulation of β2 × β1-AR by isoproterenol had no eﬀect
on Akt phosphorylation as compared to basal conditions.
Thus chimeric β1 × β2-AR increased Akt phosphorylation
and conﬁrmed that the carboxy-terminal tail of the β2-AR
contained molecular determinants necessary and suﬃcient
for PI-3K activation.
3.6. Eﬀect of Pertussis Toxin Treatment on β-ARStimulationof
PI3-K Activity. It has been proposed that stimulation of PI-
3K by β2-AR is pertussis toxin sensitive [1, 12]. To determine
the eﬀect of pertussis toxin on β-AR induced stimulation of
PI-3K,weincubatedthecellswithPTXfor18hoursfollowed
byastimulationwith1μMisoproterenolfor15minutes.Our
results indicate that, in presence of PTX, no activation of PI-
3K was observed with β2-AR stimulation (Figure 7(b)). In
presence of the chimeric receptors, PTX treatment abolished
the activation of PI-3K observed with the chimeric β1 × β2-
AR (Figure 7(d)). Consistent with our earlier data, neither
the β1-AR (Figure 7(a)) nor the β2 × β1-AR (Figure 7(c))
wassensitivetoPTXpretreatment.Theseresultsindicatethat
stimulation of PI-3K by β2-AR is pertussis toxin sensitive.
3.7. Involvement of PI-3K Activation on β-AR Sequestration.
Cellsexpressingβ1-ARweretreatedwithisoproterenolfor15
minutes. After stimulation, very little β1-AR was observed in
the interior compartments of treated cells and no signiﬁcant
diﬀerence was observed in presence of either cotransfected
p85ΔPI-3K or PTX pretreatment (Figures 8(a) to 8(d)). In
contrast, we observed a signiﬁcant internalization of β2-AR
after a similar period of agonist stimulation as shown by
clustered distribution of the receptor (Figure 8(f); outline of
the cell is poorly deﬁned in this particular condition). β2-
AR internalization was inhibited in the presence of either
cotransfected p85ΔPI-3K or PTX pretreatment (Figures 8(g)
and 8(h)). These results conﬁmed that functional PI-3K
is important for the sequestration of β2-AR and attests to
the eﬀectiveness of our p85ΔPI-3K cotransfection or PTX
pretreatment.
4. Discussion
The results of the current study demonstrate that stimu-
lation of β2-AR, but not β1-AR, induces PI-3K activation
by a pertussis toxin-sensitive mechanism. This subtype-
dependentactivationhasbeenreinforcedbythefactthatAkt,
a downstream PI-3K eﬀector, was also selectively activated
by β2-AR stimulation. However, both receptor subtypes
can recruit the PI-3K to the plasma membrane via a Gβγ
subunit-dependent mechanism. Naga Prasad et al. [2]h a d
previously demonstrated that PI-3K and GRK2 formed a
cytosolic complex and the recruitment of the enzyme to
the plasma membrane was facilitated by Gβγ subunits in
an agonist-dependent manner. Our results conﬁrmed that
PI-3K is recruited to the plasma membrane via a Gβγ
subunit-dependent mechanism. GRK-2 is important for PI-
3K recruitment to the plasma membrane, thus we thought
this might suggest that the carboxyl-terminal domain of
the receptor is important for the PI-3K activation because
the carboxyl-terminal domain of the β-AR contains sites
phosphorylated by GRK2. Furthermore, Shiina et al. [13]
had demonstrated that the carboxyl-terminal domain and6 International Journal of Cell Biology
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Figure 7: Pertussis toxin eﬀects on β-AR-mediated PI-3K activation. Twenty-six hours after transfection, cells were incubated with 0.1μg/mL
pertussis toxin for 18 hours. Cells were stimulated for 5 minutes with 1μM isoproterenol prior to processing for TLC as described in Figure 1
and Section 2. PI-3K activity was determined by the level of [32P]-PI produced by the stimulation of β1-AR (a), β2-AR (b), β2 × β1-AR (c),
and β1 ×β2-AR expressing cells. (n = 3-4; ∗P<. 05 versus basal and PTX-Iso conditions).
thethirdcytosoliclooparetheregionsmostlyresponsiblefor
thediﬀerenceininternalizationbehaviorbetweenboth β-AR
subtypes.
To determine the potential contribution of the carboxyl-
terminal domains of the β1-a n dβ2-AR in the PI-3K
activation, chimeric β1-a n dβ2-AR in which the seventh
transmembrane domain and the carboxyl-terminal domain
have been exchanged were constructed. We observed that the
chimeric β1 × β2-AR could activate PI-3K in contrast to the
wild type β1-AR. Reciprocally, β2-AR lost its ability to acti-
vatePI-3Kwhenitscarboxy-terminaldomainwasexchanged
for that of the β1-AR. This result demonstrated that the β2-
AR carboxyl-terminal domain contains important molecular
determinants for PI-3K activation.
The present study conﬁrms PI-3K activation by β2-AR
stimulation as observed in other studies [2, 12]. However
the kinetics of PI-3K activation previously reported for
β2-AR stimulation was diﬀerent to that observed in the
present study. PI-3K was rapidly activated following β2-AR
stimulation and returned to basal levels after 10 minutes. In
our study, we observed a signiﬁcant PI-3K activation with
a 5-minute β2-AR stimulation that was maintained after 15
minutes. The diﬀerence in activation patterns may be due
to the agonist concentration used. In the previous study [2],
10μM isoproterenol was used which is 10 times higher than
theconcentrationusedhere.Higherconcentrationofagonist
may induce more rapid PI-3K recruitment to the membrane
and thus activation of the enzyme but may also more rapidly
stimulate mechanisms which terminate these signals as well.
Pretreatment with pertussis toxin results in a loss of
PI-3K activation by β2-AR stimulation conﬁrming results
obtained in other studies [1, 12]. The new information
aﬀorded by the present study is that the carboxy-terminal
portion of the receptor is important for the interaction
between the receptor, Gi heterotrimers (as stimulation
depends on both the Gα and Gβγ subunits), and PI-3K.
Indeed, the chimeric receptor β1 × β2-AR can activate the
PI-3K by a pertussis toxin sensitive mechanism whereas
the chimeric receptor β2 × β1-AR is unable to activate PI-
3K. However, other regions of the receptor may also be
important for full activation or regulation of the response by
the desensitization machinery.
Our results demonstrate that isoproterenol-stimulated
β1-AR (for up to 15 minutes) cannot activate PI-3K. TheseInternational Journal of Cell Biology 7
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Figure 8: p85ΔPI-3K reduced agonist-induced β2-AR sequestration. HEK 293 cells were transfected with p85ΔPI-3K and the two β-AR
subtypes. Cells were stimulated with 1μM isoproterenol for 15 minutes (b) and (f). Stimulation of β2-AR-transfected cells induced a cluster
distribution which is characteristic of receptor internalization (f). This sequestration was abolished in presence of either cotransfected
p85ΔPI-3K (g) or PTX pretreatment (h). No signiﬁcant β1-AR sequestration was observed under the diﬀerent conditions used in these
experiments (a)–(d). Representative images of several experiments (n = 8–15) are shown.
results contrast with those reported in a previous study in
which activation of PI-3K was observed after stimulation of
β1-ARtransfectedintoHEK293cells[2].Severalpossibilities
canexplainthediscrepancybetweenbothstudies.First,1μM
isoproterenol although suﬃcient to induce submaximal
adenylyl cyclase activity [8] cannot induce PI-3K activation.
Secondly, in our study we use transiently transfected cells
that express approximately 500fmol receptor/mg of mem-
brane proteins, which is closer to physiological levels than
seen with the study of Naga Prasad et al. [2]. Also, it is clear
that the interplay between the signalling and internalization
machinery is diﬀerent for the two receptors even though
they can interact with many of the same proteins. This study
provides another such example that both β1-AR and β2-AR
lead to PI-3K and GRK2 recruitment; both the signalling
and desensitization outcomes for these events are markedly
diﬀerent. Some studies have also shown that β1-AR, in
contrast to the β2-AR, cannot activate Gi [14] while others
s u g g e s tt h a ti tc a n[ 15]. It is possible that other cell- and
tissue-speciﬁc factors might regulate these events as well.
In this study, we observed that β2-AR internalization
is inhibited in the presence of a dominant negative PI-
3K, p85ΔPI-3K, results that are similar to previous studies
[2, 16]. We also observed that β2-AR sequestration can be
abolished with pertussis toxin pretreatment. In contrast to
β2-AR, we observed that the β1-AR sequestration is minimal
with 15 minutes of stimulation. This is similar to the 10%
sequestration observed in β1-AR expressing cells obtained by
Suzuki et al. [17]. Since phosphorylated lipids generated by
PI-3K are critical for the receptor internalization dynamics
[18, 19], it is plausible that the weak sequestration observed
for the β1-AR might be due to the weak PI-3K activation
induced by the stimulation of this receptor subtype. Results
obtained with the pertussis pretreatment and p85ΔPI-3K
also suggest that activated PI-3K is important for receptor
sequestration.
In conclusion, we observed that PI-3K activation is β-
AR subtype speciﬁc and the diﬀerence is due to molecular
determinants present in the carboxy-terminal tail of the
receptors. PI-3K activation is pertussis toxin sensitive and is
necessary for the sequestration of the β2-AR.
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